Montelukast

Alternative Names: Singulair

Singulair (Montelukast) is a leukotriene receptor antagonist that treats allergic rhinitis and asthma by blocking leukotrienes, which cause inflammation, swelling, and mucus production. It is especially effective for nasal congestion and is a convenient once-daily oral tablet, making it a good option for those who prefer pills over nasal sprays.

Singulair is beneficial for people with both asthma and allergies and can be combined with antihistamines for additional relief. It is best suited for individuals with persistent allergic rhinitis who do not get enough relief from other treatments.

Treatment Type: Prescription Medication

Treatment Class: Leukotriene antagonist

Treatment Modality: Oral

Review Summary

4.0

1 Reviews

Preferred by 1 Reviewers

Based on the single review provided, Montelukast (Singulair) is considered a second-line or add-on therapy for treating Allergic Rhinitis. The reviewer, a doctor, rates the treatment as 4 out of 5, indicating its effectiveness; however, they also warn about the potential risk of neuropsychiatric side effects, particularly in children and teenagers, suggesting caution when using this medication.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
5.0
1 = Very Expensive 5 = Very Affordable

5.0

Very Affordable
Relief Speed
3.0
1 = No Relief 5 = Immediate Relief

3.0

Moderate Relief
Side Effects
3.0
1 = Intolerable Effect 5 = No Effect

3.0

Moderate Effect
Treatment Line
3.0
1 = Third-line or more 5 = First-line

3.0

Second Line

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

4.0

1 Reviews
5
0%
4
100%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the single review provided, Montelukast (Singulair) is considered a second-line or add-on therapy for treating Allergic Rhinitis. The reviewer, a doctor, rates the treatment as 4 out of 5, indicating its effectiveness; however, they also warn about the potential risk of neuropsychiatric side effects, particularly in children and teenagers, suggesting caution when using this medication.

Reviews

Filter by reviewer type Pro

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
5 months ago
Singulair is a second-line or add-on therapy for allergic rhinitis. Because of the risk of neuropsychiatric side effects, Singulair should be used with caution, especially in children and teenagers.
#VeryAffordable #CoveredByInsurance #ModerateRelief #ModerateEffect #Second-line #Maintenance